HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


EL: Estee Lauder Companies Inc - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
ESTEE LAUDER COMPANIES INC (NYSE)
EL 48.22 0.72 (1.52%) Vol.  1,202,618 16:03 ET
Estee Lauder Co. is one of the world's leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. Its products are sold in numerous countries and territories under the following well-recognized brand names: Estee Lauder, Clinique, Aramis, Prescriptives, Origins, M.A.C, Bobbi Brown essentials, La Mer, jane, Aveda, Stila, Jo Malone and Bumble and bumble. The company is also the global licensee for fragrances and cosmetics sold under the TommyHilfiger, Donna Karan and Kate Spade brands.

 General Information
ESTEE LAUDER
767 Fifth Avenue
New York, NY 10153
Phone: 212 572-4200
Fax: 212-572-3941
Web: www.elcompanies.com
Email: irdept@estee.com
 
Industry COSMETICS&TLTRS
Sector: Consumer Staples
 
Fiscal Year End June
Last Reported Quarter 09/30/09
Next EPS Date 02/04/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 47.50
52 Week High 48.68
52 Week Low 19.26
Beta 1.16
20 Day Moving Average 2,820,560.25
Target Price Consensus 49.59
 
 % Price Change
4 Week 16.57
12 Week 38.47
YTD 55.20
 % Price Change Relative to S&P 500
4 Week 12.12
12 Week 25.00
YTD 27.94
 Share Information
Shares Outstanding (millions) 196.74
Market Capitalization (millions) 9,453.21
Short Ratio 4.45
Last Split Date 06/03/1999
 Dividend Information
Dividend Yield 1.14%
Annual Dividend $0.55
Payout Ratio 0.27
Change in Payout Ratio 0.03
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.88
Current Year EPS Consensus Estimate 2.24
Estimated Long-Term EPS Growth Rate 15.70
Next EPS Report Date 02/04/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.40
30 Days Ago 2.64
60 Days Ago 2.64
90 Days Ago 2.64

 Fundamental Ratios
 P/E
Current FY Estimate: 21.48
Trailing 12 Months: 23.91
PEG Ratio 1.37
 EPS Growth
vs. Previous Year 226.92%
vs. Previous Quarter 325.00%
 Sales Growth
vs. Previous Year -3.68%
vs. Previous Quarter: 8.95%
 Price Ratios
Price/Book 5.09
Price/Cash Flow 15.83
Price / Sales 1.30
 ROE
09/30/09 23.33
06/30/09 16.80
03/31/09 21.62
 ROA
09/30/09 7.53
06/30/09 5.38
03/31/09 6.99
 Current Ratio
09/30/09 2.05
06/30/09 2.00
03/31/09 2.01
 Quick Ratio
09/30/09 1.51
06/30/09 1.45
03/31/09 1.44
 Operating Margin
09/30/09 5.47
06/30/09 3.82
03/31/09 4.71
 Net Margin
09/30/09 6.43
06/30/09 4.68
03/31/09 7.38
 Pre-Tax Margin
09/30/09 6.43
06/30/09 4.68
03/31/09 7.38
 Book Value
09/30/09 9.44
06/30/09 8.34
03/31/09 8.40
 Inventory Turnover
09/30/09 2.18
06/30/09 2.11
03/31/09 2.07
 Debt-to-Equity
09/30/09 0.75
06/30/09 0.85
03/31/09 0.85
 Debt to Capital
09/30/09 42.80
06/30/09 46.26
03/31/09 46.39

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research